|
1
|
Takane K, Midorikawa Y, Yamazaki S,
Kajiwara T, Yoshida N, Kusumi Y and Takayama T: Gastrointestinal
stromal tumor with nephrotic syndrome as a paraneoplastic syndrome:
A case report. J Med Case Rep. 8(108)2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Zech P, Colon S, Pointet P, Deteix P,
Labeeuw M and Leitienne P: The nephrotic syndrome in adults aged
over 60: Etiology, evaluation and treatment of 76 cases. Clin
Nephrol. 17:232–236. 1982.PubMed/NCBI
|
|
3
|
Galloway J: Remarks on Hodgkin's disease.
Br Med J. 2:1201–1208. 1922.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Lee JC, Yamauchi H and Hopper J Jr: The
association of cancer and the nephrotic syndrome. Ann Intern Med.
64:41–51. 1966.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Vivarelli M, Emma F, Pellé T, Gerken C,
Pedicelli S, Diomedi-Camassei F, Klaus G, Waldegger S, Ronco P and
Debiec H: Genetic homogeneity but IgG subclass-dependent clinical
variability of alloimmune membranous nephropathy with anti-neutral
endopeptidase antibodies. Kidney Int. 87:602–609. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Cattran DC, Appel GB, Hebert LA, Hunsicker
LG, Pohl MA, Hoy WE, Maxwell DR and Kunis CL: North America
Nephrotic Syndrome Study Group. Cyclosporine in patients with
steroid-resistant membranous nephropathy: A randomized trial.
Kidney Int. 59:1484–1490. 2001.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Beck LH Jr and Salant DJ: Membranous
nephropathy: Recent travels and new roads ahead. Kidney Int.
77:765–770. 2010.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Beck LH Jr, Fervenza FC, Beck DM, Bonegio
RG, Malik FA, Erickson SB, Cosio FG, Cattran DC and Salant DJ:
Rituximab-induced depletion of Anti-PLA2R autoantibodies predicts
response in membranous nephropathy. J Am Soc Nephrol. 22:1543–1550.
2011.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Polanco N, Gutiérrez E, Covarsí A, Ariza
F, Carreño A, Vigil A, Baltar J, Fernández-Fresnedo G, Martín C,
Pons S, et al: Spontaneous remission of nephrotic syndrome in
idiopathic membranous nephropathy. J Am Soc Nephrol. 21:697–704.
2010.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ye WL, Tang N, Wen YB, Li H, Li MX, Du B
and Li XM: Underlying renal insufficiency: The pivotal risk factor
for Pneumocystis jirovecii pneumonia in immunosuppressed patients
with non-transplant glomerular disease. Int Urol Nephrol.
48:1863–1871. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Fujita F, Ishii S, Hirano S, Izumi S,
Takeda Y and Kobayashi N: Response of paraneoplastic nephrotic
syndrome to corticosteroids combined with chemotherapy for advanced
lung cancer: A case report and literature review. Int Canc Conf J.
1:88–92. 2012.
|
|
12
|
Hauber HP: Paraneoplastic syndromes in
lung cancer. Pneumologie. 65:347–358. 2011.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Miret M, Horváth-Puhó E, Déruaz-Luyet A,
Sørensen HT and Ehrenstein V: Potential paraneoplastic syndromes
and selected autoimmune conditions in patients with non-small cell
lung cancer and small cell lung cancer: A population-based cohort
study. PLoS One. 12(e0181564)2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Jensen AD, Münter MW, Bischoff H,
Haselmann R, Timke C, Krempien R, Sterzing F, Nill S, Heeger S,
Hoess A, et al: Treatment of non-small cell lung cancer with
intensity-modulated radiation therapy in combination with
cetuximab: The NEAR protocol. BMC Cancer. 6(12)2006.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Huo X, Huo B, Wang H, Wang L, Cao Q, Zheng
G, Wang J, Chai S, Zhang Z, Yang K, et al: Implantation of computed
tomography-guided Iodine-125 seeds in combination with chemotherapy
for the treatment of stage III non-small cell lung cancer. J
Contemp Brachytherapy. 9:527–534. 2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Martinez-Monge R, Pagola M, Vivas I and
López-Picazo JM: CT-guided permanent brachytherapy for patients
with medically inoperable early-stage non-small cell lung cancer
(NSCLC). Lung Cancer. 61:209–213. 2008.PubMed/NCBI View Article : Google Scholar
|
